Kevin Lee
CEO & Executive DirectorDr. Kevin Lee, M.B.A., Ph.D., is Director of Alchemab Therapeutics Ltd. He has been Chief Executive Officer of Bicycle Therapeutics plc since September 2015. Dr. Lee joined Bicycle Therapeutics from Pfizer where he served as Senior Vice President and Chief Scientific Officer of the Rare Disease Research Unit. In that role, he held responsibility for more than 20 novel programs across the full spectrum of R&D, established Pfizer's Rare Disease strategy, conceptualized and implemented the company's Gene Therapy strategy with the creation of the Genetic Medicine Institute and also founded the Rare Disease research consortium. Before joining GlaxoSmithKline, Dr. Lee was a lecturer at Warwick University Medical School and founded Cambridge Biotechnology Ltd, which specialized in developing small molecule and peptide therapeutics for inflammation and metabolic diseases before its trade sale to Biovitrum in 2005 and Neurosolutions (now Oncosil Medical Ltd ASX). Prior to joining Pfizer, he worked at GSK and as well as leading the formation of multiple strategic commercial and academic partnerships, he led epigenetics research and was responsible for the creation of the EpiNova DPU. He serves as Venture Partner at SV7 Impact Medicine Fund LP. Dr. Lee currently serves as a non-executive director at the private biotechnology companies Alchemab Ltd., a position he has held since June 2021 and Macomics Ltd., a position he has held since July 2023. He has experience in drug discovery and development leadership. He is an accomplished leader with a proven track record developing novel biopharmaceuticals and business collaborations across therapeutic areas. He serves as Independent Director at NodThera Limited. He serves as Executive Director of Bicycle Therapeutics plc since September 2015.
Positions
- Company NameBicycle Therapeutics plcStock CodeBCYCPositionCEO & Executive DirectorColleagues
- FJFelix James BakerIndependent Chairman
- MSMichael SkynnerChief Scientific Officer
- AMAlistair MilnesChief Corporate Development Officer
- CHChristian HeinisScientific Founder
- TTTravis ThompsonChief Financial Officer
- JGJose-Carlos Gutierrez-RamosIndependent Non-Executive Director and Member of Research & Innovation Advisory Board
- SSStephen SandsIndependent Director
- HHHerve HoppenotIndependent Director
